Corporate Presentation

Download Now


OKYO Pharma granted new patent for OK-101 to treat neuropathic pain
OKYO Pharma to take dry eye disease drug direct into Phase 2 clinical trials
OKYO Pharma announces key engagement with Ora Inc to develop its novel dry eye drug
OKYO Pharma CEO talks promising pre-clinical data for its acute and chronic ocular pain drug